Should Nano-particles Be Used to Cross Blood Brain Barrier to Deliver Drugs to Neurodegenerative Disease?

Madhuri Sharon
Additional contact information
Madhuri Sharon: Department of Nanotechnology, Walchand College of Arts & Science, India

Novel Approaches in Drug Designing & Development, 2017, vol. 1, issue 1, 10-11

Abstract: Treating diseases of central nervous system by delivering therapeutic agents faces a big problem of crossing blood brain barrier. For combating this challenge various types of nano particles such as polymeric nano particles, nano metals, carbon quantum dots are being used with reasonable success in crossing the BBB and enhancing the drug efficacy. However, certain aftermath negative impact of use of nanotechnology for drug delivery to brain has not been considered. In this opinion/short-communication attention has been paid to the need of considering various aspects that may cause damage to brain.

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555554.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555554.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:1:y:2017:i:1:p:10-11

DOI: 10.19080/NAPDD.2017.01.555554

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().